Lexicon Pharmaceuticals Inc (LXRX) — Cash Flow Quality Index

Latest as of June 2025: 5.23x

Lexicon Pharmaceuticals Inc (LXRX) has a Cash Flow Quality Index of 5.23x as of June 2025. Operating cash flow of $16.99 Million exceeds net income of $3.25 Million, indicating high earnings quality where cash backs reported profits. Also explore balance sheet size of Lexicon Pharmaceuticals Inc for the complete picture of this company's asset base.

Cash Flow Quality Index

5.23x
Operating CF / Net Income

Operating Cash Flow

$16.99 Million
USD

Net Income

$3.25 Million
USD

Data as of

Jun 2025
Most recent filing

Lexicon Pharmaceuticals Inc Cash Flow Quality Index (2019–2019)

Historical Cash Flow Quality Index for Lexicon Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LXRX tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Lexicon Pharmaceuticals Inc (2019–2019)

Year-by-year earnings quality comparison for Lexicon Pharmaceuticals Inc. For live market cap and the full company financial profile, see Lexicon Pharmaceuticals Inc market cap and net worth.

Year Quality Index Operating CF (USD) Net Income YoY Change
2019 0.87x $113.81 Million $130.13 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.